Sanofi offers to acquire Kiadis for €308 million

NEXT STORY
Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention
PREV STORY
Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SUNRISE HOSPITAL REPORTS ON LAS VEGAS MASS CASUALTY

Las Vegas, NV, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Sunrise Hospital and Medical Center, ...

author_avatar
NASDAQ Market News

Scilex Announces Pricing and Availability of ZTlido™ for the Commercial Launch of its First Product in October of 2018

SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (Scilex), a subsidiary ...

author_avatar
NASDAQ Market News

Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the 2018 American Society for Clinical Oncology Annual Meeting

Abstract Data Show Overall Response Rate of 60% in 25 Advanced Melanoma Patients Naïve ...

author_avatar
NASDAQ Market News